• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英国建立 SARS-CoV-2 的最佳疫苗接种策略模型。

Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.

机构信息

The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, United Kingdom.

出版信息

PLoS Comput Biol. 2021 May 6;17(5):e1008849. doi: 10.1371/journal.pcbi.1008849. eCollection 2021 May.

DOI:10.1371/journal.pcbi.1008849
PMID:33956791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8101958/
Abstract

The COVID-19 outbreak has highlighted our vulnerability to novel infections. Faced with this threat and no effective treatment, in line with many other countries, the UK adopted enforced social distancing (lockdown) to reduce transmission-successfully reducing the reproductive number R below one. However, given the large pool of susceptible individuals that remain, complete relaxation of controls is likely to generate a substantial further outbreak. Vaccination remains the only foreseeable means of both containing the infection and returning to normal interactions and behaviour. Here, we consider the optimal targeting of vaccination within the UK, with the aim of minimising future deaths or quality adjusted life year (QALY) losses. We show that, for a range of assumptions on the action and efficacy of the vaccine, targeting older age groups first is optimal and may be sufficient to stem the epidemic if the vaccine prevents transmission as well as disease.

摘要

新冠疫情爆发凸显了我们对新型感染的脆弱性。面对这一威胁,又没有有效的治疗方法,英国与许多其他国家一样,采取了强制性的社会隔离(封锁)措施来减少传播,成功地将繁殖数 R 降低到 1 以下。然而,考虑到仍然存在大量易感人群,如果完全放松控制,很可能会引发大规模的进一步爆发。疫苗接种仍然是控制感染和恢复正常互动和行为的唯一可预见手段。在这里,我们考虑在英国境内进行疫苗接种的最佳目标,旨在将未来的死亡人数或质量调整生命年(QALY)损失降到最低。我们表明,对于疫苗的作用和功效的一系列假设,首先针对老年人群体是最优的,如果疫苗能够预防传播和疾病,那么可能足以阻止疫情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/c9193a2f7b1b/pcbi.1008849.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/fb123d085553/pcbi.1008849.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/fdd4ce7405ac/pcbi.1008849.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/476de66be9fa/pcbi.1008849.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/4ff2327d1230/pcbi.1008849.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/5cfde7aa54eb/pcbi.1008849.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/9462f2daafee/pcbi.1008849.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/40bee0109db4/pcbi.1008849.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/c0e83e50b471/pcbi.1008849.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/c9193a2f7b1b/pcbi.1008849.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/fb123d085553/pcbi.1008849.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/fdd4ce7405ac/pcbi.1008849.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/476de66be9fa/pcbi.1008849.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/4ff2327d1230/pcbi.1008849.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/5cfde7aa54eb/pcbi.1008849.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/9462f2daafee/pcbi.1008849.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/40bee0109db4/pcbi.1008849.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/c0e83e50b471/pcbi.1008849.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b8/8101958/c9193a2f7b1b/pcbi.1008849.g009.jpg

相似文献

1
Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.在英国建立 SARS-CoV-2 的最佳疫苗接种策略模型。
PLoS Comput Biol. 2021 May 6;17(5):e1008849. doi: 10.1371/journal.pcbi.1008849. eCollection 2021 May.
2
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.英国新冠病毒疫苗接种与保持社交距离相结合的潜在健康和经济价值:基于传播模型的未来情景分析与经济评估
Lancet Infect Dis. 2021 Jul;21(7):962-974. doi: 10.1016/S1473-3099(21)00079-7. Epub 2021 Mar 18.
3
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
4
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
5
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.2019冠状病毒病的疫苗接种与非药物干预措施:一项数学建模研究
Lancet Infect Dis. 2021 Jun;21(6):793-802. doi: 10.1016/S1473-3099(21)00143-2. Epub 2021 Mar 18.
6
Are COVID vaccination programmes working? Scientists seek first clues.新冠疫苗接种计划是否有效?科学家们寻找初步线索。
Nature. 2021 Jan;589(7843):504-505. doi: 10.1038/d41586-021-00140-w.
7
Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.利用罗德岛和马萨诸塞州实时发病率估计值优化 SARS-CoV-2 疫苗分配。
BMC Med. 2021 Jul 13;19(1):162. doi: 10.1186/s12916-021-02038-w.
8
Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.调整 COVID-19 疫苗接种期间公共卫生、旅行和社会措施的效果:建模研究。
Lancet Public Health. 2021 Sep;6(9):e674-e682. doi: 10.1016/S2468-2667(21)00167-5. Epub 2021 Aug 11.
9
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中,疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征:一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
10
Lockdowns and the COVID-19 pandemic: What is the endgame?封锁和 COVID-19 大流行:结局是什么?
Scand J Public Health. 2021 Feb;49(1):37-40. doi: 10.1177/1403494820961293. Epub 2020 Sep 26.

引用本文的文献

1
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.一种基于网络的模型,用于通过贝叶斯优化评估针对新冠疫情的疫苗接种策略。
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
2
A hybrid approach based on ELECTRE III-genetic algorithm and TOPSIS method for selection of optimal COVID-19 vaccines.一种基于ELECTRE III-遗传算法和TOPSIS方法的混合方法用于选择最佳的新冠疫苗。
J Multi Criteria Decis Anal. 2022 Jan-Apr;29(1-2):80-91. doi: 10.1002/mcda.1772. Epub 2021 Nov 15.
3
Understanding Nash epidemics.

本文引用的文献

1
Lessons from past pandemics: a systematic review of evidence-based, cost-effective interventions to suppress COVID-19.从过去的大流行病中吸取的教训:系统评价有证据支持、具有成本效益的干预措施以抑制 COVID-19。
Syst Rev. 2022 May 12;11(1):90. doi: 10.1186/s13643-022-01958-9.
2
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number.符合英国 COVID-19 疫情情况,短期预测和估计繁殖数。
Stat Methods Med Res. 2022 Sep;31(9):1716-1737. doi: 10.1177/09622802211070257. Epub 2022 Jan 17.
3
Vaccine optimization for COVID-19: Who to vaccinate first?
理解纳什流行病。
Proc Natl Acad Sci U S A. 2025 Mar 4;122(9):e2409362122. doi: 10.1073/pnas.2409362122. Epub 2025 Feb 27.
4
Evaluating the effectiveness of vaccination campaigns: Insights from unvaccinated mortality data.评估疫苗接种运动的效果:来自未接种疫苗者死亡率数据的见解。
Infect Dis Model. 2024 Dec 5;10(1):365-373. doi: 10.1016/j.idm.2024.12.004. eCollection 2025 Mar.
5
Quantifying age-specific household contacts in Aotearoa New Zealand for infectious disease modelling.为传染病建模量化新西兰奥塔哥地区特定年龄段的家庭接触情况。
R Soc Open Sci. 2024 Oct 2;11(10):240550. doi: 10.1098/rsos.240550. eCollection 2024 Oct.
6
Vaccination strategies for different contact patterns: weighing epidemiological against economic outcomes.针对不同接触模式的疫苗接种策略:权衡流行病学结果与经济结果。
Int J Health Econ Manag. 2025 Mar;25(1):131-157. doi: 10.1007/s10754-024-09384-1. Epub 2024 Sep 24.
7
Prioritising older individuals for COVID-19 booster vaccination leads to optimal public health outcomes in a range of socio-economic settings.优先为老年人接种新冠病毒加强针疫苗,可在一系列社会经济环境中带来最佳的公共卫生效果。
PLoS Comput Biol. 2024 Aug 8;20(8):e1012309. doi: 10.1371/journal.pcbi.1012309. eCollection 2024 Aug.
8
When should lockdown be implemented? Devising cost-effective strategies for managing epidemics amid vaccine uncertainty.何时应该实施封锁?在疫苗不确定的情况下制定具有成本效益的传染病管理策略。
PLoS Comput Biol. 2024 Jul 18;20(7):e1012010. doi: 10.1371/journal.pcbi.1012010. eCollection 2024 Jul.
9
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先排序模型的系统综述
Infect Dis Model. 2024 May 15;9(4):1057-1080. doi: 10.1016/j.idm.2024.05.005. eCollection 2024 Dec.
10
Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.呼吸道病原体症状传播的流行病学和健康经济学意义:一项数学建模研究。
PLoS Comput Biol. 2024 May 3;20(5):e1012096. doi: 10.1371/journal.pcbi.1012096. eCollection 2024 May.
2019冠状病毒病疫苗优化:优先接种对象为谁?
Sci Adv. 2021 Feb 3;7(6). doi: 10.1126/sciadv.abf1374. Print 2020 Feb.
4
Predictions of COVID-19 dynamics in the UK: Short-term forecasting and analysis of potential exit strategies.预测英国的 COVID-19 动态:短期预测和潜在退出策略分析。
PLoS Comput Biol. 2021 Jan 22;17(1):e1008619. doi: 10.1371/journal.pcbi.1008619. eCollection 2021 Jan.
5
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.家庭传播 SARS-CoV-2 及武汉地区易感性和传染性的危险因素:一项回顾性观察研究。
Lancet Infect Dis. 2021 May;21(5):617-628. doi: 10.1016/S1473-3099(20)30981-6. Epub 2021 Jan 18.
6
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.SARS-CoV-2 刺突糖蛋白疫苗候选物 NVX-CoV2373 在食蟹猴中的免疫原性和在小鼠中的保护作用。
Nat Commun. 2021 Jan 14;12(1):372. doi: 10.1038/s41467-020-20653-8.
7
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
8
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey.英国的 COVID-19 疫苗接种意愿:来自 COVID-19 疫苗可接受性研究(CoVAccS)的结果,这是一项全国代表性的横断面调查。
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621. doi: 10.1080/21645515.2020.1846397. Epub 2020 Nov 26.